Evidence for lecanemab in early Alzheimer’s disease

Overview of attention for article published in Drug & Therapeutics Bulletin, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 9 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,799 followers.

Top 🔟 DTB articles published in 2023 Number 8️⃣ in the list of most accessed articles: DTB Select: Evidence for lecanemab in early Alzheimer’s disease https://t.co/cl04JLKGMV https://t.co/JLuZwI5yHQ

31 Jan 2024

Reply Repost Favourite

"Evidence for lecanemab in early Alzheimer’s disease" - read our summary of the study that assessed the effect of lecanemab in people with early Alzheimer's disease. Do the findings support the hype of the early press releases? https://t.co/cl04JLK8Xn http

09 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.